Platelet Function and Serum High Density Lipoproteins

 

PDF Download Buy Article Permissions and Reprints

Summary

Two groups of healthy male subjects one with low (mean 1.03 mmol/1), and the other with normal (mean 1.80 mmol/1), concentrations of high density lipoprotein (HDL) cholesterol in plasma were investigated. A series of in vitro platelet function tests were performed in order to investigate a possible connection between low HDL concentration, which has been defined as an independent risk factor for the occurrence of CHD, and disturbances in platelet function.

No significant differences in platelet function were observed between the two groups. A positive correlation was found between platelet factor 3 activity both in platelet rich and platelet poor plasma and the plasma concentration of HDL.

• References

• 1 Ali M, Mcdonald JW D. 1977; Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin. Journal of Laboratory and Clinical Medicine 89: 868
  PubMedGoogle Scholar
• 2 Baker K, Joist JH, Kay DM, Schonfeld G. 1976; Increased platelet function in hyperlipoproteinemia?. Circulation (abstr.) 53 (11) 116
  PubMedGoogle Scholar
• 3 Born GV R. 1962; Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927
  PubMedGoogle Scholar
• 4 Bruyere DeM, Bellenot C, Sokal G. 1974; Electronic platelet counting after isopycnic differential centrifugation. A simple rapid and accurate method. Thrombosis et Diathesis Haemor- rhagica 32: 232
  PubMedGoogle Scholar
• 5 Burstein M, Scholnik HR, Morfin R. 1970; Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. Journal of Lipid Research 11: 583
  PubMedGoogle Scholar
• 6 Carvalho AC A, Colman RW, Lees RS. 1974; Platelet function in hyperlipoproteinemia. New England Journal of Medicine 290: 434
  CrossrefPubMedGoogle Scholar
• 7 Colman RW. 1978; Platelet function in hyperbetalipoproteinemia. Thrombosis et Haemostasis 39: 284
  PubMedGoogle Scholar
• 8 Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. 1977; High density Lipoprotein as a protective factor against coronary heart disease. American Journal of Medicine 62: 707
  CrossrefPubMedGoogle Scholar
• 9 Miller NE, Førde OH, Thelle D, Mjøs OD. 1977; High density lipoprotein and coronary heart disease: A prospective case control study. Lancet 1: 965
  PubMedGoogle Scholar
• 10 Lowry HO, Rosebrough NJ, Lewis Farr A, Randall RJ. 1951; Protein measurements with the folin phenol reagent. Journal of Biological Chemistry 193: 265
  PubMedGoogle Scholar
• 11 Ludlam CA, Moore S, Bolton AE, Pepper DS, Cash JD. 1975; The release of a human platelet specific protein measured by a radioimmunoassay. Thrombosis Research 6: 543
  CrossrefPubMedGoogle Scholar
• 12 Miller ME, Nordø A. 1977; Effects of human plasma lipoproteins on platelet aggregation and platelet factor 3 activity in vitro. Atherosclerosis 28: 181
  CrossrefPubMedGoogle Scholar
• 13 Mjøs OD, Thelle DS, Forde OH, Vik-Mo H. 1977; Family study of high density lipoprotein cholesterol and the relation to age and sex. Acta Medica Scandinavica 201: 323
  PubMedGoogle Scholar
• 14 Nordøy A, Rodset JM. 1971; Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia: effect of nicotinic acid and clofibrate. Acta Medica Scandinavica 189: 385
  PubMedGoogle Scholar
• 15 Nordøy A, Strøm E, Gjesdal K. 1974; The effect of alimentary hyperlipaemia and primary hypertriglyceridaemia on platelets in man. Scandinavian Journal of Haematology 12: 329
  PubMedGoogle Scholar
• 16 Nordøy A, Svensson B, Wiebe P, Hoak JC. 1978; Lipoproteins and the inhibitory effect of human endothelial cells on platelet function. Circulation Research 43: 527
  CrossrefPubMedGoogle Scholar
• 17 Sandberg H, Andersson LO. 1979 A highly sensitive assay of platelet factor 3 using a chromogenic substrate. Thrombosis Research. in press
  PubMedGoogle Scholar
• 18 Sandberg H, Andersson LO. 1976; Studies on the thromboplastic effect of human plasma lipoproteins. Thrombosis et Haemostasis 35: 178
  PubMedGoogle Scholar
• 19 Smith JB, Ingerman CM, Kocsis JJ, Silver MJ. 1974; Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. The Journal of Clinical Investigation 53: 1468
  CrossrefPubMedGoogle Scholar
• 20 Smith JB, Ingerman CM, Silver MJ. 1976; Malondialdehyde formation as an indicator of prostaglandin production by human platelets. Journal of Laboratory and Clinical Medicine 88: 167
  PubMedGoogle Scholar
• 21 Wu KK, Hoak JC. 1974; A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 2: 924
  PubMedGoogle Scholar